This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hornef, M. W. Articles by Kirchner, H. Search for Related Content PubMed PubMed Citation Articles by Hornef, M. W. Articles by Kirchner, H.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, Mar 1995, 209-213, Vol 2, No. 2
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Cytokine production in a whole-blood assay after Epstein-Barr virus infection in vivo

MW Hornef, HJ Wagner, A Kruse and H Kirchner
Institute of Immunology and Transfusion Medicine, School of Medicine, University of Lubeck, Germany.

Epstein-Barr virus (EBV) has a marked tropism for cells of the immune system, and infection can result in profound immunomodulatory effects. In order to examine the role of cytokines during the acute phase of infectious mononucleosis, we studied the levels of different interleukins (ILs), interferons (IFNs), and the soluble IL-2 receptor (sIL-2R) in serum samples of 20 patients. We found elevated levels of IL-2, IL-6, sIL-2R, and IFN-gamma. Whereas the peak of IL-2 and IL-6 concentration occurred during the first week (P < 0.01), the largest amounts of sIL-2R were measured during the second week (P < 0.01). IFN- gamma levels were only enhanced during the first week. In addition, we investigated the ability to produce cytokines in response to mitogenic stimulation in a whole-blood assay of 11 patients compared with healthy blood donors. In the whole-blood assay of patients compared with controls after stimulation with lipopolysaccharide, we measured more than 10-fold elevated levels of tumor necrosis factor alpha (P < 0.01), 3-fold elevated levels of IL-1 beta (P < 0.01), and about 2-fold increased amounts of IL-6 (P < 0.01). A significant enhancement in sIL- 2R and IFN-gamma concentration was found in the assay after stimulation with phytohemagglutinin after 24 h of incubation (P < 0.01). Collectively, our data seem to indicate that monocytes are strongly activated during infectious mononucleosis. Monocytes and monocyte- derived factors may play an important role in the pathogenesis of infectious mononucleosis and, together with T lymphocytes, may be partly responsible for clinical symptoms.

This article has been cited by other articles:

• Yasui, Y., Potter, J. D., Stanford, J. L., Rossing, M. A., Winget, M. D., Bronner, M., Daling, J. (2001). Breast Cancer Risk and "Delayed" Primary Epstein-Barr Virus Infection. Cancer Epidemiol. Biomarkers Prev. 10: 9-16 [Abstract] [Full Text]  
• Roberge, C. J., McColl, S. R., Larochelle, B., Gosselin, J. (1998). Granulocyte-Macrophage Colony-Stimulating Factor Enhances EBV-Induced Synthesis of Chemotactic Factors in Human Neutrophils. J. Immunol. 160: 2442-2448 [Abstract] [Full Text]  
• Prang, N. S., Hornef, M. W., Jager, M., Wagner, H. J., Wolf, H., Schwarzmann, F. M. (1997). Lytic Replication of Epstein-Barr Virus in the Peripheral Blood: Analysis of Viral Gene Expression in B Lymphocytes During Infectious Mononucleosis and in the Normal Carrier State. Blood 89: 1665-1677 [Abstract] [Full Text]